These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30535835)

  • 1. Demand and Supply Motivations for Antiretroviral Drugs in Illicit Street Markets: The Case of Atlanta, Georgia.
    Saravia A; Mueller R
    AIDS Behav; 2019 Aug; 23(8):2079-2087. PubMed ID: 30535835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations.
    Tsuyuki K; Surratt HL; Levi-Minzi MA; O'Grady CL; Kurtz SP
    AIDS Behav; 2015 May; 19(5):857-68. PubMed ID: 25092512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.
    Kurtz SP; Buttram ME; Surratt HL
    AIDS Care; 2014 Apr; 26(4):411-5. PubMed ID: 24033118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida.
    Surratt HL; Kurtz SP; Cicero TJ; O'Grady C; Levi-Minzi MA
    Am J Public Health; 2013 Jun; 103(6):1026-8. PubMed ID: 23597362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "The number of clients is increasing but the supplies are reducing": provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited settings: a qualitative study from Uganda.
    Zakumumpa H; Kiweewa FM; Khuluza F; Kitutu FE
    BMC Health Serv Res; 2019 May; 19(1):312. PubMed ID: 31092245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Inciardi JA; Surratt HL; Kurtz SP; Cicero TJ
    Pain Med; 2007 Mar; 8(2):171-83. PubMed ID: 17305688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Savvy Sellers: Dealing Drugs, Doing Gender, and Doing Difference.
    Ludwick MD; Murphy S; Sales P
    Subst Use Misuse; 2015 May; 50(6):708-20. PubMed ID: 26086305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men.
    Buttram ME; Kurtz SP
    AIDS Behav; 2019 Jul; 23(7):1790-1796. PubMed ID: 30255385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for a risky business: How drug dealers manage customers, suppliers and competitors in Italy, Slovenia and Germany.
    Tzvetkova M; Pardal M; Disley E; Rena A; Talic S; Forberger S
    Int J Drug Policy; 2016 May; 31():90-8. PubMed ID: 27161385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The make or buy debate: considering the limitations of domestic production in Tanzania.
    Wilson KR; Kohler JC; Ovtcharenko N
    Global Health; 2012 Jun; 8():20. PubMed ID: 22747578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines.
    Kohler JC; Chang Pico T; Vian T; Mackey TK
    Clin Pharmacol Ther; 2018 Dec; 104(6):1054-1056. PubMed ID: 30076604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV antiretroviral medication stock-outs in Ghana: contributors and consequences.
    Poku RA; Owusu AY; Mullen PD; Markham C; McCurdy SA
    Afr J AIDS Res; 2017 Sep; 16(3):231-239. PubMed ID: 28978293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals.
    Varshney K; Browning SD; Debnath SK; Shet P; Shet D
    AIDS Behav; 2023 Feb; 27(2):558-577. PubMed ID: 35895149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
    Ankomah A; Ganle JK; Lartey MY; Kwara A; Nortey PA; Okyerefo MP; Laar AK
    BMC Infect Dis; 2016 Dec; 16(1):738. PubMed ID: 27927183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.
    van Griensven J; De Naeyer L; Uwera J; Asiimwe A; Gazille C; Reid T
    BMC Pediatr; 2008 Oct; 8():39. PubMed ID: 18831747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
    Pryce C; Pierre RB; Steel-Duncan J; Evans-Gilbert T; Palmer P; Moore J; Rodriguez B; Christie CD
    West Indian Med J; 2008 Jun; 57(3):238-45. PubMed ID: 19583122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambiguous diagnosis, futile treatments and temporary recovery: meanings of medical treatment among HIV/AIDS family caregivers providing care without ARVs.
    Makoae M
    SAHARA J; 2011; 8(4):187-96. PubMed ID: 23236960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.